Caisse De Depot Et Placement Du Quebec Biomarin Pharmaceutical Inc Transaction History
Caisse De Depot Et Placement Du Quebec
- $53.5 Billion
- Q3 2025
A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 913,163 shares of BMRN stock, worth $50 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
913,163
Previous 637,269
43.29%
Holding current value
$50 Million
Previous $35 Million
41.18%
% of portfolio
0.09%
Previous 0.08%
Shares
30 transactions
Others Institutions Holding BMRN
# of Institutions
666Shares Held
182MCall Options Held
1.48MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$833 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$804 Million0.46% of portfolio
-
State Street Corp Boston, MA8.76MShares$480 Million0.02% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...